Investornewsbreaks Silo Pharma Inc. (NASDAQ: SILO) Strengthens Patent Portfolio With Approval For PTSD Treatment SPC-15
Silo Pharma (NASDAQ: SILO) received a Notice of Allowance from the U.S. Patent and Trademark Office for a key patent supporting its lead asset, SPC- ...